Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Efficacy of Biolimus Drug-Coated Balloon (DCB) Versus Drug-Eluting Stent (DES) in the Treatment of De Novo Coronary Artery Lesions

NCT07582250 is registered in ClinicalTrials.gov with JW Medical Systems Ltd as lead sponsor.

NCT NCT07582250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Efficacy of Biolimus Drug-Coated Balloon (DCB) Versus Drug-Eluting Stent (DES) in the Treatment of De Novo Coronary Artery Lesions
Lead sponsor
JW Medical Systems Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 31, 2030
Enrollment
1,548 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

patients with de novo coronary artery lesions